Ledger.Open graph →
SEC Form D · filed June 22, 2017

Viking Therapeutics, Inc

Offering
$3.7M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Brian Lian · San Diego, CAExec · DirectorStephen W. Webster · San Diego, CADirectorMatthew W. Foehr · LA JOLLA, CADirectorJ. M. Singleton · San Diego, CADirectorLawson Macartney · San Diego, CADirectorMichael Morneau · San Diego, CAExecStephen W. Webster · San Diego, CADirectorMatthew W. Foehr · LA JOLLA, CADirectorJ. M. Singleton · San Diego, CADirectorLawson Macartney · San Diego, CADirectorMichael Morneau · San Diego, CAExecBrian Lian · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗